Rosiglitazone and other thiazolidinediones are thought to sensitize adipose and other tissues to insulin by activating a molecule called PPARγ. A recent study suggests that the therapeutic effect of rosiglitazone is mediated by its prevention of the phosphorylation of PPARγ.
PDF的下载单位、IP信息已删除
(2025-6-4)
无极微光
didiwang
chandangfo
vc
学术文献互助
白兰猫
科研狗
lizishu
贪玩的秋柔
pluto
畔畔
GingerF
xjcy
子车茗
8R60d8
dew
漪涙
昏睡的蟠桃
pcr163
大力的灵雁
皖公网安备34019202002308
